Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Space Peptides is a biopharmaceutical company specializing in the discovery and development of next-generation macrocyclic peptide therapeutics. Utilizing its proprietary SPACE platform, the company focuses on creating highly stable and potent cyclic peptides that can address challenging intracellular and extracellular targets traditionally considered undruggable. Their research spans multiple high-impact therapeutic areas, including oncology, metabolic disorders, and infectious diseases. By integrating advanced mRNA display technology with structural biology, Space Peptides aims to accelerate the transition of peptide candidates from discovery to clinical application.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Space Peptides.